Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

f. uhlmann-eyraud ag - tixocortoli pivalas, neomycinum - nasensuspension - tixocortoli-21 pivalas 10 mg, neomycinum 3,5 mg per neomycini sulfas, conserv.: cetylpyridinii chloridum, alcol benzylicus, excipiens a sospensione, per 1 g. - batterica superinfektion a rhinitiden - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - sal marinum, dexpanthenolum - nasensalbe - sal marinum 10 mg, dexpanthenolum 50 mg, sorbitolum liquidum cristallisabile, glyceroli monostearas 40-55, macrogoli aether cetostearylicus, adeps solidus, macrogolglyceridorum oleates, macrogolglyceridorum laurates, vaselinum album, e 200 0.75 mg, e 219 0.75 mg, aqua purificata ad unguentum pro 1 g. - secca rhinitiden - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - mupirocinum - nasensalbe - mupirocinum 20 mg ut mupirocinum calcicum dihydricum, excipiens ad unguentum pro 1 g. - eliminazione di intranasalen stafilococchi nei portatori - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - fluticasoni propionas - nasentropfen, suspension in einzeldosen - fluticasoni propionas 400 µg, polysorbatum 20, sorbitani lauras, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, aqua ad iniectabile, ad suspensionem pro 0.4 ml. - corticosteroidi-rhinologikum per il trattamento di polipi nasali - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - budesonidum - nasenspray, suspension - budesonidum 50 µg, glucosum, cellulosum microcristallinum et carmellosum natricum, e 202 60 µg, polysorbatum 80, dinatrii edetas, acidum hydrochloridum, aqua purificata ad suspensionem pro dosi. doses pro vase 200. - la rinite - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - budesonidum - nasenspray, suspension - budesonidum 100 µg, glucosum, cellulosum microcristallinum et carmellosum natricum, e 202 60 µg, polysorbatum 80, dinatrii edetas, acidum hydrochloridum, aqua purificata ad suspensionem pro dosi. doses pro vase 200. - la rinite - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - fluticasoni furoas - nasenspray, suspension - fluticasoni furoas 27.5 µg, glucosum, cellulosum dispergibile, polysorbatum 80, dinatrii edetas, benzalkonii chloridum 8.25 µg, aqua purificata, ad suspensionem pro dosi, doses pro vase 120. - la rinite - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - virus influenzae a (h1n1) vivus attenuatum (virus-stamm a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/1/2020, medi 340505)), virus influenzae a (h3n2) vivus attenuatum (virus-stamm a/darwin/9/2021 (h3n2)-like a/norway/16606/2021 (medi 355293)), virus influenzae b vivus attenuatum (virus-stamm b/austria/1359417/2021-like b/austria/1359417/2021 (medi 355293, victoria lineage)) - nasenspray, suspension - virus influenzae a (h1n1) vivus attenuatum (virus-stamm a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/1/2020, medi 340505)) 70 mio. ffu, virus influenzae a (h3n2) vivus attenuatum (virus-stamm a/darwin/9/2021 (h3n2)-like a/norway/16606/2021 (medi 355293)) 70 mio. ffu, virus influenzae b vivus attenuatum (virus-stamm b/austria/1359417/2021-like b/austria/1359417/2021 (medi 355293, victoria lineage)) 70 mio. ffu, virus influenzae b vivus attenuatum (virus-stamm b/phuket/3073/2013-like: b/phuket/3073/2013 (medi 306444, yamagata lineage)) 70 mio. ffu, saccharum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, gelatina hydrolysata, arginini hydrochloridum, natrii hydrogenoglutamas monohydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.2 ml. - aktive immunisierung gegen influenza für kinder und jugendliche im alter von 2-18 jahren - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

g-pharma ag - xylometazolini hydrochloridum, dexpanthenolum - nasenspray lösung - xylometazolini hydrochloridum 1 mg/ml corrisp. xylometazolini hydrochloridum 100 µg per dosi, dexpanthenolum 50 mg/ml corrisp. dexpanthenolum 5 mg pro dosi, excipiens ad una soluzione per 1 ml, dosi per il serbatoio 100. - raffreddore - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - azelastini hydrochloridum, fluticasoni propionas - nasenspray, suspension - azelastini hydrochloridum 0.137 mg, fluticasoni propionas 0.05 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, polysorbatum 80, dinatrii edetas, alcohol phenylethylicus, benzalkonii chloridum 0.014 mg, aqua purificata, ad suspensionem pro dosi, doses pro vase 120. - symptomatische behandlung der saisonalen allergischen rhinitis und rhinokonjunktivitis. - synthetika